Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The compound acts in a similar manner to various glucagon receptors, as well as commonly used peptides such as glucagon-like peptide 1 (GLP-1) Current research is focused on the use of glucagon receptors and peptides such as GLP-3R to prevent the development and advance the treatment for chronic epidemics such as obesity and type 2 diabetes
Diabetes Metab J (2015) 39(4):3427
But their benefits dont stop there
Additional sources: Supplier data (purity 99%, blend ratio 1:1, research-only status)
Ask your provider about insurance coverage options, savings cards, manufacturer rebates, or support programs that can help make treatment more affordable
Type 2 diabetes affects over 37 million Americans, with many requiring multiple medications to reach target blood glucose levels
